The role of Fas in the immune system biology of IL-2Rα knockout mice: Interplay among regulatory T cells, inflammation, hemopoiesis, and apoptosis

Journal of Immunology

Volumn 175, Issue 3, 2005, Pages 1965-1973

  Sharma, Rahul ^a   Bagavant, Harini ^a   Jarjour, Wael N ^a   Sung, Sun Sang J ^a   Ju, Shyr Te ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; INTERLEUKIN 2 RECEPTOR ALPHA;

ANEMIA; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW; COLON; CONTROLLED STUDY; GENE MUTATION; HEART; HEMATOPOIESIS; IMMUNE SYSTEM; INFLAMMATION; KIDNEY; KNOCKOUT MOUSE; LACRIMAL GLAND; LIVER; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; LYMPHOID ORGAN; LYMPHOPOIESIS; MOUSE; NONHUMAN; OVARY; PANCREAS; PHENOTYPE; PRIORITY JOURNAL; SALIVARY GLAND; SMALL INTESTINE; STOMACH; T LYMPHOCYTE; THYROID GLAND; WEIGHT REDUCTION;

EID: 22544431621     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.3.1965     Document Type: Article

References (31)

1. Malek, T. R. 2003. The main function of IL-2 is to promote the development of T regulatory cells. J. Leukocyte Biol. 74: 961-965.
2. Nelson, B. H. 2004. IL-2, regulatory T cells, and tolerance. J. Immunol. 172: 3983-3988.
3. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16: 81-88.
4. von Herrath, M. G., and L. C. Harrison. 2003. Antigen-induced regulatory T cells in autoimmunity. Nat Rev. Immunol. 3: 223-232.
5. Kojima, A., and R. T. Prehn. 1981. Genetic susceptibility to post-thymectomy autoimmune disease in mice. Immunogenetics 14: 15-27.
6. Bagavant, H., S. Adams, P. Terranova, A. Chang, F. W. Kraemer, Y. Lou, K. Kasai, A. M. Luo, and K, S. Tung. 1999. Autoimmune ovarian inflammation triggered by proinflammatory (Th1) T cells is compatible with normal ovarian function in mice. Biol. Reprod. 61: 635-642.
7. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
8. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261.
9. Kramer, S., A, Schimpl, and T. Hunig. 1995. Immunopathology of interleukin (IL) 2-deficient mice: Thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J. Exp. Med. 182: 1769-1776.
10. Contractor, N. V., H. Bassiri, T. Reya, A. Y. Park, D. C. Baumgart, M. A. Wasik, S, G. Emerson, and S. R. Carding. 1998. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J. Immunol. 160: 385-394.
11. Poussier, P., T. Ning, J. Chen, D. Banerjee, and M. Julius. 2000. Intestinal inflammation observed in IL-2R/IL-2 mutant mice is associated with impaired intestinal T lymphopoiesis. Gastroenterology 118: 880-891.
12. Schultz, M., S. H. Clarke, L. W. Arnold, R. B. Sartor, and S. L. Tonkonogy. 2001. Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice. Immunology 104: 127-134.
13. Willerford, D. M. J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521-530.
14. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. Simard, P. S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268: 1472-1476.
15. Suzuki, H., Y. W. Zhou, M. Kato, T. W. Mak, and I. Nakashima. 1999. Normal regulatory α/β T cells effectively eliminate abnormally activated T cells lacking the interleukin-2 receptor β in vivo. J. Exp. Med. 190: 1561-1572.
16. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
17. Lynch, D. H., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, et al. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131-136.
18. D'Souza, S. D., B. Bonetti, V. Balasingam, N. R. Cashman, P. A. Barker, A. B. Troutt, C. S. Raine, and J. P. Antel. 1996. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184: 2361-2370.
19. Stassi, G., R. De Maria, G. Trucco, W. Rudert, R. Testi, A. Galluzzo, C. Giordano, and M. Trucco. 1997. Nitric oxide primes pancreatic β-cells for Fas-mediated destruction in IDDM. J. Exp. Med. 186: 1193-1200.
20. Giordano, C., G. Stassi, R. De Maria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi, and A. Galluzzo. 1997. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275: 960-963.
21. Xiao, S., S. S. Sung, S. M. Fu, and S. T. Ju. 2003. Combining Fas mutation with interleukin-2 deficiency prevents colitis and lupus: implicating interleukin-2 for auto-reactive T cell expansion and Fas ligand for colon epithelial cell death. J. Biol. Chem. 278: 52730-52738.
22. Seino, K., K. Iwabuchi, N. Kayagaki, R. Miyata, I. Nagaoka, A. Matsuzawa, K. Fukao, H. Yagita, and K. Okumura. 1998. Chemotactic activity of soluble Fas ligand against phagocytes. J. Immunol. 161: 4484-4488.
23. Jacobson, B. A., D. J. Panka, K. A. Nguyen, J. Erikson, A. K. Abbas, and A. Marshak-Rothstein. 1995. Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 3: 509-519.
24. Mizuno, T., X. Zhong, and T. L. Rothstein. 2003. Fas-induced apoptosis in B cells. Apoptosis 8: 451-460.
25. + T cells protect IL-2 receptor α-deficient mice from systemic infection with herpes simplex virus type 2. J. Immunol. 165: 4552-4560.
26. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, et al. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264: 965-968.
27. Waldmann, T. 2002. The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases. Arthritis Res. 4(Suppl. 3): S161-S167.
28. Marks-Konczalik, J., S. Dubois, J. M. Losi, H. Sabzevari, N. Yamada, L. Feigenbaum, T. A. Waldmann, and Y. Tagaya. 2000. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc. Natl. Acad. Sci. USA 97: 11445-11450.
29. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191: 771-780.
30. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669-676.
31. Roifman, C. M. 2000. Human IL-2 receptor α chain deficiency. Pediatr. Res. 48: 6-11.